Technical and immunologic progress in simultaneous pancreas-kidney transplantation.

BACKGROUND During the past few years the use of new immunosuppressants and refinements in surgical technique of simultaneous pancreas-kidney (SPK) transplantation have resulted in markedly improved outcomes. This is a retrospective study of 208 SPK transplants performed at Northwestern University, demonstrating the advances made at a single center that are reflective of the field at large. METHODS An 8.5-year time span was split into 4 distinct eras marking sequential changes in immunosuppression and surgical technique that ensued. SPK transplant outcomes of patient and graft survival and rejection rates were compared. Also examined were end points related to the changing risk profile of the recipients, as well as quality of allograft function and rates of rehospitalizations. RESULTS Recipients receiving tacrolimus/mycophenolate mofetil-based immunosuppression had patient, kidney, and pancreas survival rates significantly higher than those of earlier cohorts. The elimination of corticosteroids did not reduce survival rates or increase rejection risk. The use of pancreatic exocrine enteric drainage technique over bladder drainage reduced rehospitalizations. CONCLUSIONS Advances in immunosuppression management combined with technical refinements have made SPK transplantation a safer and more effective treatment option for the diabetic, uremic patient.

[1]  M. Abecassis,et al.  A PROSPECTIVE STUDY OF RAPID CORTICOSTEROID ELIMINATION IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION: Comparison of Two Maintenance Immunosuppression Protocols: Tacrolimus/Mycophenolate Mofetil Versus Tacrolimus/Sirolimus1 , 2002, Transplantation.

[2]  M. Abecassis,et al.  RISK FACTORS AND IMPACT OF CYTOMEGALOVIRUS DISEASE IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION , 2001, Transplantation.

[3]  R. Stratta,et al.  Multicenter survey of daclizumab induction in simultaneous kidney-pancreas transplant recipients. , 2001, Transplantation.

[4]  D. Dunn,et al.  Lessons Learned From More Than 1,000 Pancreas Transplants at a Single Institution , 2001, Annals of surgery.

[5]  M. Abecassis,et al.  Simultaneous pancreas-kidney transplantation in the mycophenolate mofetil/tacrolimus era: evolution from induction therapy with bladder drainage to noninduction therapy with enteric drainage. , 2000, Surgery.

[6]  R. Merion,et al.  Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation. , 2000, Transplantation.

[7]  F. Reinholt,et al.  Area under the serum creatinine time-curve is a strong predictor of chronic renal allograft rejection. , 2000, Transplantation.

[8]  R. Stratta,et al.  A prospective comparison of systemic-bladder versus portal-enteric drainage in vascularized pancreas transplantation. , 1998, Surgery.

[9]  D. Sutherland,et al.  Pancreas transplant outcomes for United States (US) cases reported to the United Network for Organ Sharing (UNOS) and non-US cases reported to the International Pancreas Transplant Registry (IPTR) as of October, 2000. , 2000, Clinical transplants.

[10]  D. Dunn,et al.  Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. , 1999, Annals of surgery.

[11]  M. Abecassis,et al.  Mycophenolate mofetil and tacrolimus as primary maintenance immunosuppression in simultaneous pancreas-kidney transplantation: initial experience in 50 consecutive cases. , 1999, Transplantation.

[12]  S. Knechtle,et al.  A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation. , 1998, Transplantation.

[13]  S. Knechtle,et al.  Posttransplant infection in enteric versus bladder-drained simultaneous pancreas-kidney transplant recipients. , 1998, Transplantation.

[14]  S. Knechtle,et al.  Experience with 500 simultaneous pancreas-kidney transplants. , 1998, Annals of surgery.

[15]  C. Larsen,et al.  Drainage of the exocrine pancreas in clinical transplantation: comparison of bladder versus enteric drainage in a consecutive series. , 1997, Clinical transplantation.

[16]  P. Williams,et al.  Urologic complications following pancreas transplantation , 1997 .

[17]  P. Kuo,et al.  Simultaneous pancreas/kidney transplantation--a comparison of enteric and bladder drainage of exocrine pancreatic secretions. , 1997, Transplantation.

[18]  D. Dunn,et al.  Intra-abdominal fungal infections after pancreatic transplantation: incidence, treatment, and outcome. , 1996, Journal of the American College of Surgeons.

[19]  D. Sutherland,et al.  Pancreas transplant results in the United Network for Organ Sharing (UNOS) United States of America (USA) Registry compared with non-USA data in the International Registry. , 1994, Clinical transplants.

[20]  E. Messing,et al.  Urological Complications in 210 Consecutive Simultaneous Pancreas‐Kidney Transplants with Bladder Drainage , 1993, Annals of surgery.

[21]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .